TL;DR: Brain mapping records your brain’s electrical activity and turns it into a picture of how regions fire and communicate. It cannot diagnose a condition or promise a result, but it gives your clinical team objective data to personalize and adjust treatment. At RYSE Wellness, qEEG is repeated three times during a residential stay so you can see change over the course of care.
Medically reviewed by Veronica Anderson, Clinical/Medical Director. Last reviewed July 2026.
Brain mapping shows how the brain’s electrical activity relates to mood, attention, and connectivity through quantitative EEG (qEEG), a scalp-based test that measures brainwave activity across frequency bands. It is one input among many, read alongside your history and symptoms. This guide is for adults, families, and referring clinicians exploring residential care in Fallbrook and North County San Diego.
Because a map is only useful when a clinical team acts on it, brain mapping sits inside a broader plan of care. At RYSE, qEEG is part of our residential mental health program for adults, where the data informs psychiatry, therapy, and neuromodulation decisions. It is not a standalone scan or a diagnosis.

Key Takeaways
- What maps reveal: qEEG shows patterns in brainwave power, left-right asymmetry, and network connectivity that clinicians compare against typical ranges to inform care.
- Not a diagnosis: qEEG is non-diagnostic. It supports clinical judgment and never replaces a full history, exam, and symptom review.
- Serial mapping tracks change: RYSE performs FDA-cleared qEEG three times during a residential stay (intake, midway, discharge) via Firefly Neuro so progress is measurable.
- Testing is quick and noninvasive: A baseline qEEG session typically takes 20 to 40 minutes, with no radiation and only sensors resting on the scalp.
- It guides real decisions: Maps help inform TMS targeting, medication review by psychiatry, and therapy focus, always interpreted by qualified clinicians.
Want to know whether brain-mapped residential care is covered by your plan? Start with a free, confidential verification of benefits, often completed the same day.
What brain mapping actually shows
On a practical level, a brain map highlights consistent differences in electrical signals across frequency bands, regions, and connections. Clinicians read these as patterns, not as answers by themselves.
Common findings include increased or decreased power in bands such as alpha or theta, which can reflect states like cortical idling or underactivation. Frontal asymmetry, where one side shows different activity than the other, is sometimes studied in relation to mood.
Maps can also show altered connectivity between regions, suggesting how network communication may be disrupted. If a clinician adds an event-related potential task (ERP, a brief brain response time-locked to a stimulus), it can reveal differences in processing speed or attention.
The table below summarizes the core signals a qEEG report describes and what each one broadly reflects.
What qEEG measures
| Signal | Frequency / definition | What it broadly reflects |
|---|---|---|
| Delta | 0.5 to 4 Hz | Slow waves common in deep sleep, or diffuse dysfunction when seen while awake |
| Theta | 4 to 8 Hz | Drowsiness, memory encoding, and some attention processes; excess can suggest cognitive slowing |
| Alpha | 8 to 12 Hz | Rises during relaxed, eyes-closed rest; changes often reflect arousal or inhibitory control |
| Beta | 12 to 30 Hz | Alert thinking and motor readiness; high beta can correlate with anxiety or hyperarousal |
| Gamma | 30 Hz and up | Fast rhythms in high-level processing; interpreted cautiously because of noise |
| Coherence / connectivity | Region-to-region signal tracking | How well two areas communicate, suggesting connection or disconnection |
| Asymmetry | Left-right power difference | Differences between hemispheres in the same band, studied in mood research |
For a plain-language primer on the test itself, see our explainer on what qEEG brain mapping is.
What qEEG patterns look like across conditions
Group-level studies describe electrical patterns that often differ across conditions such as depression, anxiety, PTSD, and ADHD. These are population trends, not results that diagnose any single person. The National Institute of Mental Health notes that depression involves brain regions and circuits that regulate mood, part of why clinicians study functional brain activity.
The table below shows typical, illustrative findings. Read it as patterns researchers observe across groups, not as a personal readout.
Typical qEEG patterns by condition (illustrative, group-level)
| Condition | Commonly described pattern | What it may suggest | How clinicians use it |
|---|---|---|---|
| Depression | Frontal alpha asymmetry, altered anterior theta | Differences in mood and reward circuits | Informs discussion of TMS targeting and psychiatric review |
| Anxiety / PTSD | Elevated high-beta, reduced posterior alpha | Hyperarousal and reduced cortical inhibition | Supports a focus on downregulation and trauma-focused therapy |
| ADHD (adults) | Elevated theta-to-beta ratio, slower processing | Relative under-arousal in attention networks | Helps match attention concerns to a treatment plan |
| Treatment-resistant depression | Specific asymmetry and theta patterns | Possible modifiable nodes in mood networks | One input, with history, when planning next steps |
Medication, caffeine, sleep loss, and recording noise can all shift these signals, so no single marker stands alone. If low mood is part of your picture, our article on the signs of high-functioning depression offers additional context.
How to read your qEEG report
A qEEG report compares your recording against a normative database, a reference sample of people without the condition, matched to your age. This comparison is what turns raw brainwaves into something a clinician can interpret.
Most reports show two things. The first is a set of topographic maps, often called heat maps, that use color to show where a given rhythm is stronger or weaker across your scalp.
The second is a set of numbers, frequently z-scores. A z-score (a standardized value showing how many standard deviations a measurement sits from the reference average) tells the clinician how far a signal is from typical, and in which direction.
A large deviation is a signpost worth discussing, not a verdict. Clinicians weigh it against your history, symptoms, and goals before it means anything for your care.
When you review your report, it is reasonable to ask a few questions. Ask what each map shows compared with typical ranges, whether anything needs prompt follow-up, and whether you can receive copies of the raw data and the written report for continuity of care.
How clinicians use brain maps to personalize care
A brain map becomes useful only when it is combined with your psychiatric history, validated symptom scales, and clinical goals. At RYSE, clinicians pair qEEG data with in-house TMS and AI-informed treatment planning that the care team reviews before any decision.

For TMS, a map can help inform the discussion of where a provider focuses stimulation, such as which hemisphere or region a clinician considers, always within FDA-cleared protocols. The map contributes to that conversation; it does not set the protocol on its own.
For medication, serial maps give psychiatry another reference point when reviewing whether a current regimen appears to be helping, alongside symptom scales and your reported experience. qEEG does not select a medication or a dose. Prescribers do, using their clinical judgment.
AI-informed planning at RYSE supports the clinical team by organizing measurable data. It does not diagnose or make treatment decisions on its own, and clinicians remain responsible for every choice. To see how mapping fits our clinical model, visit our qEEG brain mapping therapy page.
What brain mapping does not show
Brain mapping is informative but never definitive, and understanding its limits protects you as a patient. qEEG measures electrical activity, not anatomy, so it cannot by itself detect structural problems like a tumor or stroke. Those require imaging such as MRI or CT.
Results are also sensitive to real-world factors. The most common sources of distortion are worth knowing before your session:
- Muscle tension: Jaw clenching or a tight forehead adds high-frequency noise that can look like excess beta.
- Eye movement: Blinks create large slow signals, most visible in frontal sensors.
- Electrode contact: Poor contact raises impedance and can distort or drop a channel.
- Medications: Stimulants, benzodiazepines, and some other medications shift spectral power.
- Sleep and caffeine: Sleep loss or a recent coffee can change alpha and theta and mimic slowing.
Two errors follow from this. A false positive happens when artifact makes normal activity look abnormal, and a false negative happens when a real pattern is masked by a noisy recording.
Clinicians reduce these by checking electrode impedance, coaching you to relax your jaw and hold a steady gaze, and repeating noisy segments rather than averaging a bad recording. Structural imaging is ordered separately when there is a focal neurological sign, a sudden change, or a seizure. Expect qEEG to be one input among many, never used in isolation.
How qEEG compares with EEG, MRI, and CT
People often ask how brain mapping relates to the scans they already know. The short answer is that these tests answer different questions, and they are frequently complementary rather than competing.
A standard EEG and a qEEG both record electrical activity, but they are read differently. A neurologist reads a standard EEG visually, often to look for seizure activity, while qEEG adds a statistical comparison against a normative database.
MRI and CT are structural scans. They show anatomy, such as soft tissue, bleeds, or lesions, rather than moment-to-moment function. The table below lays out the differences.
qEEG vs. other common brain tests
| Test | What it measures | What it shows | Typical role |
|---|---|---|---|
| qEEG | Electrical activity, quantified vs. norms | Functional patterns in rhythms and connectivity | Adjunctive input for treatment personalization |
| Standard EEG | Electrical activity, read visually | Events such as seizure activity | Diagnostic for certain neurological conditions |
| MRI | Anatomy via magnetic imaging | Detailed soft-tissue structure | Rules out or identifies structural causes |
| CT | Anatomy via X-ray imaging | Bone, bleeds, and gross structure | Fast structural check in urgent settings |
Because qEEG is functional rather than structural, it complements imaging rather than replacing it. Your clinician decides when a structural scan is also warranted.
What to expect during a qEEG session at RYSE
A baseline qEEG session typically takes 20 to 40 minutes, and if a clinician adds an ERP task it can run 10 to 30 minutes more. A little preparation makes the recording clearer.
Before your visit, a short checklist helps:
- Arrive with clean, dry hair and skip heavy products like gel, oil, or hairspray.
- Bring a current medication list and photo ID.
- Wear comfortable clothing and avoid large metal jewelry.
- Tell the team about any seizure history or implanted devices on arrival.
Staff will review your history, then place a soft cap or individual sensors after briefly cleaning the skin for good contact. This can feel cool but is not painful, and you can ask for a break at any time.
During the recording you sit quietly, usually with periods of eyes open and eyes closed, while the system captures your brainwave activity. You stay awake throughout and can stop whenever you need to.
Afterward, a clinician reviews your topographic maps and numeric summaries with you in plain language. Ask when a formal report will be ready, since some reviews happen the same day and others follow after processing.
Why RYSE repeats brain mapping three times
One map is a snapshot, so RYSE performs qEEG three times during a residential stay: at intake, midway, and discharge. This lets clinicians build a true baseline, check early response, and document change over the course of care.
At intake, the baseline profile shows your dominant rhythms, asymmetries, and connectivity before treatment begins. The midway scan is an early check on whether TMS, medication adjustments, or therapy are moving metrics in a helpful direction.
At discharge, the final map documents objective change and helps shape aftercare recommendations you can share with outpatient providers. Meaningful change is a consistent shift across several metrics and time points, not a single color change on one heatmap.
Repeating maps does not promise any outcome. It gives you and your family measurable information about how your brain responded while you were in care.
How to choose a brain-mapping provider
If you are comparing options, a few practical questions separate a serious clinical program from a standalone scan. Use this checklist before you refer or enroll.
- Device clearance: Ask whether the system is FDA-cleared for clinical qEEG use, and note that the FDA clears devices for specific intended uses, which is different from FDA approval.
- Normative comparison: Confirm the provider compares your data against a validated, age-matched reference database for adults.
- Clinician interpretation: Make sure a qualified clinician interprets the map and signs the report, rather than software alone.
- Treatment integration: Prefer a program that ties maps directly to treatment planning, not a one-off scan.
- Serial mapping: Favor programs that map at the start, midpoint, and end of care so you can see change over time.
RYSE meets each of these through our residential mental health program and our clinical team, who review every map in the context of your full plan of care.
Verify your benefits and next steps
Cost and coverage vary by plan. Many families use PPO out-of-network benefits, while others choose private pay, and our admissions team can walk you through either.
The clearest next step is a free, confidential, no-obligation verification of benefits, often completed the same day, so you have real numbers before making a decision. You can also explore the full scope of care across our residential programs.
If you want brain-mapped residential care or simply have questions, contact our admissions team or call (760) 266-5430. We keep every step confidential and low-pressure so you can decide with clear information.
Frequently asked questions
Is qEEG brain mapping safe?
Yes. qEEG is noninvasive and poses minimal risk. Small sensors rest on the scalp to record electrical activity, there is no radiation, and most people feel only the sensation of wearing the cap.
Can qEEG alone diagnose a psychiatric condition?
No. qEEG does not replace clinical assessment or diagnosis. It is an adjunctive test that describes brain function and supports treatment personalization when a qualified clinician interprets it.
How is qEEG different from an MRI?
qEEG measures electrical activity and timing, giving detail about how the brain fires. MRI and CT show anatomy and structure. They answer different questions and can be complementary when imaging is clinically indicated.
Will my results change my treatment plan?
Possibly. Clinicians may use map patterns to inform medication review, TMS targeting, or therapy focus. Every decision combines your history, symptoms, and preferences, so mapping is a tool for personalization, not an automatic prescription.
Will brain mapping be repeated during a residential stay?
Yes. RYSE maps three times across your stay, so you and your team can see objective trends over time and adjust care accordingly.
Does insurance help pay for care?
It can. Many clients use PPO out-of-network benefits, and our team runs a free verification of benefits to estimate coverage and out-of-pocket cost before admission.
This content is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider about your situation. If you are in crisis, call or text 988 (Suicide and Crisis Lifeline), or call 911 for an emergency.